BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38092485)

  • 1. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.
    Antić Ž; Lentes J; Bergmann AK
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101511. PubMed ID: 38092485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
    Boer JM; den Boer ML
    Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
    Den Boer ML; van Slegtenhorst M; De Menezes RX; Cheok MH; Buijs-Gladdines JG; Peters ST; Van Zutven LJ; Beverloo HB; Van der Spek PJ; Escherich G; Horstmann MA; Janka-Schaub GE; Kamps WA; Evans WE; Pieters R
    Lancet Oncol; 2009 Feb; 10(2):125-34. PubMed ID: 19138562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
    Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
    Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
    [No Abstract]   [Full Text] [Related]  

  • 5. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia.
    Jakobsen NA; Vyas P
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s47-s53. PubMed ID: 29700093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features.
    Rana NA; Mahmood A; Robert HM; Zahir S; Ali I; Riaz S
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1430-1434. PubMed ID: 36377010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification.
    Yeung DTO; Osborn MP; White DL
    Br J Haematol; 2022 Apr; 197(1):13-27. PubMed ID: 34747016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
    Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia.
    Franca R; Kuzelicki NK; Sorio C; Toffoletti E; Montecchini O; Poropat A; Rabusin M; Curci D; Paladin D; Stocco G; Decorti G
    Curr Med Chem; 2018; 25(24):2811-2825. PubMed ID: 28748759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in pediatric lymphoblastic leukemia.
    Kato M
    Int J Hematol; 2023 Feb; 117(2):155-161. PubMed ID: 36456860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia in children].
    Shimada H
    Rinsho Ketsueki; 2022; 63(7):799-804. PubMed ID: 35922951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
    Huang YH; Wan CL; Dai HP; Xue SL
    Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
    Bleckmann K; Schrappe M
    Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.
    Mroczkowska A; Jaźwiec B; Urbańska-Rakus J; Szymanowska S; Tessmann A; Pająk S; Machnik K; Haus O; Wróbel T
    BMC Med Genomics; 2022 Feb; 15(1):20. PubMed ID: 35123463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pediatric acute lymphoblastic leukemia: update on pathophysiology and management].
    Kato M
    Rinsho Ketsueki; 2018; 59(5):504-510. PubMed ID: 29877240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past.
    Short NJ; Kantarjian H
    Lancet Haematol; 2023 May; 10(5):e382-e388. PubMed ID: 37003279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult acute lymphoblastic leukemia.
    Gökbuget N; Hoelzer D
    Hematology Am Soc Hematol Educ Program; 2006; ():133-41. PubMed ID: 17124052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
    Izraeli S
    Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.